Photo taken from Manni Mohyuddin/X
Dec 26, 2023, 12:58
Manni Mohyuddin: Bispecifics and CAR-T’s in myeloma trials
Manni Mohyuddin, Assistant Professor at the Huntsman Cancer Institute at the University of Utah, shared on X:
“What we know so far about secondary primary cancers and myeloid malignancies with bispecifics and CAR-T’s in myeloma trials. Lots of unknowns.
Key to note that control arms of both randomized CAR-T trials had 0 cases of myeloid malignancies.”
Source: Manni Mohyuddin/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 4, 2025, 15:30
Feb 4, 2025, 15:27
Feb 4, 2025, 14:48
Feb 4, 2025, 14:42
Feb 4, 2025, 14:35
Feb 4, 2025, 14:22
Feb 4, 2025, 14:21